New data from the UK Health Security Agency highlights dramatic variations in hantavirus mortality depending on both the clinical syndrome and geographic region. Hantavirus pulmonary syndrome, primarily found in the Americas, demonstrates case fatality rates reaching 20% to over 50%, representing one of the most lethal forms of the infection. In contrast, haemorrhagic fever with renal syndrome, more common in Europe and Asia, exhibits significantly lower mortality rates between 1% and 15%.
These disparities reflect differences in viral species, environmental factors, and healthcare infrastructure across regions. The World Health Organization recognizes haemorrhagic fever with renal syndrome as a significant public health concern in endemic areas, particularly in parts of China, Korea, and Eastern Europe. Understanding these geographic and syndrome-specific mortality patterns is essential for healthcare professionals in assessing risk and implementing appropriate clinical management strategies.
Was this article helpful?
